Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exenatide Once Monthly Suspension in Type 2 Diabetes
NCT01104701Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- May 2010
- Primary completion
- Dec 2010
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of exenatide in type 2 diabetes mellitus (T2DM), sponsored by AstraZeneca. Started May 2010; status: completed.
02
Drugs
exenatide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01104701.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01104701.